Analystreport

Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating.

Emergent Biosolutions, Inc.  (EBS) 
Last emergent biosolutions, inc. earnings: 4/30 04:08 pm Check Earnings Report
US:NYSE Investor Relations: investors.emergentbiosolutions.com